PCN111 Cost-Effectiveness Analysis of Ixazomib PLUS Lenalidomide-Dexamethasone Versus Daratumumab PLUS Lenalidomide-Dexamethasone in Multiple Myeloma Patients Received More THAN One PRIOR Treatment in China
Abstract
Authors
X. Zhao Y. Feng L. Zhu J. Liu